Revolax is a South Korean hyaluronic acid dermal filler brand that has gained significant international recognition since its introduction to the global aesthetics market. Developed using high-purity HA and a proprietary crosslinking process, the Revolax range offers a graduated product lineup covering superficial fine line correction through to deep volumization and facial contouring. All three core products — Revolax Fine Lidocaine, Revolax Deep Lidocaine, and Revolax Sub-Q Lidocaine — incorporate lidocaine for improved patient comfort during injection.
This article provides a clinical overview of the Revolax product range, including product-specific properties, indications, and technique considerations for aesthetic practitioners. Health Supplies Plus supplies authentic Revolax dermal fillers to licensed medical professionals at wholesale pricing.
South Korean Aesthetics and the Revolax Product Philosophy
South Korea has established itself as one of the world’s most influential aesthetic medicine markets, driven by strong cultural emphasis on facial harmony, skin quality, and natural-looking enhancement. Korean aesthetic ideals — including defined facial contours, high cheekbones, and smooth, luminous skin — have shaped a demand for fillers that deliver precise, subtle results without an overdone or artificial appearance.
Revolax was developed within this environment and reflects its priorities. The brand’s emphasis on high-purity HA, consistent crosslinking, and a graduated product range designed for specific anatomical depths aligns directly with the Korean aesthetic approach of targeted, personalized treatment. The integration of lidocaine across the range also reflects the broader emphasis in Korean aesthetic practice on patient experience and procedural comfort.
Revolax Product Range: Clinical Overview
The three core Revolax products form a graduated spectrum from superficial to deep injection, allowing practitioners to match product to indication and anatomical depth with precision.
Revolax Fine Lidocaine
Revolax Fine is the lightest formulation in the range, designed for superficial injection in areas requiring fine detail correction. It uses high-purity HA with a lower crosslink density, producing a soft, smooth gel that integrates seamlessly into superficial tissue without adding structural bulk.
Primary indications: superficial fine lines and wrinkles including crow’s feet, forehead lines, and perioral lines. Revolax Fine is suited to areas with thin skin and high surface mobility where a stiffer product would risk visibility or irregularity.
Injection depth: superficial to mid-dermis.
Technique: microinjections or superficial linear threading. Even distribution is important in periorbital and perioral areas — post-injection massage may support smooth integration where appropriate.
Duration: typically 6 to 9 months depending on treatment area and patient metabolism.
Revolax Deep Lidocaine
Revolax Deep is the mid-range product, formulated for moderate to deep correction in areas requiring structural support alongside tissue integration. Its higher viscoelasticity compared to Fine allows it to maintain shape post-injection while retaining sufficient flexibility for natural movement in dynamic zones.
Primary indications: moderate to severe facial folds including nasolabial folds and glabellar lines. Also widely used for lip augmentation and definition — its viscoelasticity supports natural lip movement while providing the structure needed for volume and border definition.
Injection depth: mid-to-deep dermis.
Technique: linear threading or serial puncture for fold correction; linear threading or bolus technique along the vermilion border and into the lip body for augmentation. Start conservatively and assess at two weeks before adding volume.
Duration: typically 9 to 12 months depending on treatment area and patient factors.
Revolax Sub-Q Lidocaine
Revolax Sub-Q is the most robust product in the range, developed for high-volume, deep structural work. Its high crosslink density and large particle size provide significant lifting capacity and sustained volume in areas requiring deep tissue augmentation.
Primary indications: significant volume restoration and contouring in the cheeks, chin, and jawline. Appropriate for patients with moderate to significant mid-face deflation or those seeking structural facial reshaping.
Injection depth: deep subcutaneous to supraperiosteal. Sub-Q is not appropriate for superficial or mid-dermal injection — its high viscosity at shallow depths risks surface irregularity and product visibility.
Technique: bolus or depot injection at the supraperiosteal or deep subcutaneous level. Blunt-tip cannulas are appropriate for mid-face Sub-Q injection and reduce vascular trauma risk. Thorough post-injection moulding supports even distribution before the product integrates.
Duration: typically 12 to 18 months depending on treatment area, injection volume, and patient metabolism.
The Role of Lidocaine in the Revolax Range
All three Revolax products incorporate lidocaine — a local anesthetic — directly into the formulation. This reduces injection discomfort without requiring a separate topical or injected anesthetic step, which is a practical clinical advantage particularly in sensitive areas such as the lips and periorbital region. The lidocaine takes effect immediately upon injection, providing fast-acting comfort throughout the procedure. This is especially relevant for Sub-Q and Deep, where injection volumes and depth can increase patient awareness of the procedure.
Comparative Product Summary
| Product | Viscosity | Injection Depth | Primary Indications | Duration |
|---|---|---|---|---|
| Revolax Fine | Low | Superficial to mid-dermis | Fine lines, crow’s feet, forehead lines, perioral lines | 6–9 months |
| Revolax Deep | Medium-high | Mid-to-deep dermis | Nasolabial folds, glabellar lines, lip augmentation | 9–12 months |
| Revolax Sub-Q | High | Deep subcutaneous to supraperiosteal | Cheek volumization, chin and jawline contouring | 12–18 months |
Safety, Contraindications, and Vascular Considerations
As HA-based fillers, all three Revolax products are reversible with hyaluronidase — an essential safety consideration. Hyaluronidase must be immediately available at every session involving any Revolax product. Practitioners must be trained in vascular occlusion recognition and emergency management before performing any filler injection.
Common adverse events are mild and injection-site related: swelling, bruising, redness, and tenderness, typically resolving within a few days to one week. In the lips, swelling peaks at 24 to 48 hours — advise patients to assess results at two weeks.
Contraindications include known hypersensitivity to hyaluronic acid, lidocaine, or any product component, active infection or inflammation at the intended injection site, and pregnancy or breastfeeding. Patients with a history of severe allergic reactions or those on anticoagulant therapy require careful screening before treatment.
Current guidance from major aesthetic medicine societies does not support mandatory aspiration as a reliable standalone vascular safety measure. Primary prevention relies on slow injection speed, low pressure, small bolus volumes, and thorough anatomical knowledge of facial danger zones — particularly for Sub-Q, which is injected in deep planes close to significant vascular structures in the mid-face and jawline.
Sourcing Authentic Revolax Products
Product authenticity and cold chain integrity are fundamental to predictable clinical performance with any HA filler. Revolax products require refrigerated storage and handling in accordance with manufacturer specifications. Source exclusively through authorized channels or established, licensed B2B medical suppliers with verified supply chain traceability.
Health Supplies Plus supplies authentic Revolax Fine Lidocaine, Revolax Deep Lidocaine, and Revolax Sub-Q Lidocaine to licensed medical professionals at competitive wholesale pricing. Register your practice for free to complete one-time license verification and access our full dermal fillers catalog.
Conclusion
The Revolax range provides practitioners with a coherent, graduated HA filler lineup covering the full spectrum of non-surgical facial rejuvenation — from superficial fine line correction with Fine through to significant volumization and contouring with Sub-Q. The consistent inclusion of lidocaine across all three products improves the patient experience without requiring additional anesthetic steps. As with all HA fillers, reversibility with hyaluronidase and appropriate vascular safety practices are non-negotiable components of safe Revolax use.
Revolax Frequently Asked Questions
About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.
Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.